Accessibility settings

This paper is in the following e-collection/theme issue:

Pharmacovigilance (185) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (233) Safety and Error Prevention in Health (270) Depression and Mood Disorders; Suicide Prevention (1805) Pharmacology and Pharmaceutics (135) Intentional Self-Harm (150)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49755, first published .
Pharmacist hands holding blue lozenges blister pack and patient information leaflet

Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Authors of this article:

Soo Min Jeon1 Author Orcid Image ;   HyunJoo Lim2 Author Orcid Image ;   Hyo-bin Cheon2 Author Orcid Image ;   Juhee Ryu3 Author Orcid Image ;   Jin-Won Kwon4 Author Orcid Image
Article Authors Cited by (6) Tweetations (2) Metrics

Journals

  1. Xie W, Xiang D, Li Y, Ge M, Deng A. An exploratory study evaluating the 20 medications most commonly associated with suicidal ideation and self-injurious behavior in the FAERS database. BMC Pharmacology and Toxicology 2025;26(1) View
  2. López Carabaño A, Escudero Araus M, Docavo Barrenechea-Moxo J, Bengoechea Aldaz J. Ideación suicida por pregabalina. Caso clínico en atención primaria. Medicina de Familia. SEMERGEN 2025;51(5):102505 View
  3. Deng Y, Shi S, Feng S, Tan X, Wang Y, Yin J, Liu S, Gao Y. Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a disproportionality analysis from the FAERS database. BMC Gastroenterology 2025;25(1) View
  4. Annamalah S, Sham R, Foroughi A, Ahmed S. Socio-Economic Drivers of Drug Abuse and Criminal Activities: A Multidimensional Analysis. Deviant Behavior 2025:1 View
  5. Wang T, Yang W, Luo Y, Zhan Y, Zou F, Cui Z, Lan Y. Post-marketing safety profile of lumacaftor/ivacaftor in cystic fibrosis treatment: a pharmacovigilance analysis based on FAERS. Frontiers in Medicine 2026;13 View
  6. Artés C, Porras-Segovia A, Ruiz-Veguilla M, Giner L, Garcia-Campayo J, López del Hoyo Y, Alejandra-Saiz P, García-Fernández A, Martínez-Jambrina J, Villa-Díez R, Gili M, Roca M, de Andrés F, Pérez Sola V, Elices M, Grande I, Cebria A, Irigoyen-Otiñano M, Galván-Santiago L, Garcia-Iturrospe E, Mesones-Peral J, Mora-Marín R, Sierra P, Penas-Lledo E, LLerena A, Lopez-Castroman J, Cruz R, Arrojo M, Ovejero S, de la Torre-Luque A, Palao-Tarrero Á, Vaquero-Lorenzo C, Toma C, Barrigon M, Artes A, Díaz-Marsá M, Ayad-Ahmed W, Ibáñez Á, Díaz-Sastre C, Salvador-Robert M, Álvarez-García R, Mata-Iturralde L, Benavente-López S, Muñoz-Lorenzo L, Di Stasio E, Carmona-Camacho R, Peñuelas-Calvo I, Valencia M, López Peña P, Albarracín-García L, Baca-Garcia E. Designing interventions guided by digital phenotype and pharmacogenetics in Spain for suicidal behaviour based on retrospective data: the multicentre SMARTomicS study protocol. BMJ Open 2026;16(5):e106685 View